23  Total SME IPOs listed in 2025

1013.34 Crs.  Total funds raised in 2025

18  SME IPOs listed with Gain in 2025

5  SME IPOs listed with loss in 2025

23  Total SME IPOs listed in 2025

1013.34 Crs.  Total funds raised in 2025

18  SME IPOs listed with Gain in 2025

5  SME IPOs listed with loss in 2025

23  Total SME IPOs listed in 2025

1013.34 Crs.  Total funds raised in 2025

18  SME IPOs listed with Gain in 2025

5  SME IPOs listed with loss in 2025

23  Total SME IPOs listed in 2025

1013.34 Crs.  Total funds raised in 2025

18  SME IPOs listed with Gain in 2025

5  SME IPOs listed with loss in 2025

Senores Pharmaceuticals Limited IPO (Senores Pharmaceuticals IPO) Details

Senores Pharmaceuticals Limited is an Pharmaceutical based company, located in Ahmedabad, Senores Pharmaceuticals Limited IPO size was 582.11 Cr. and was issued at 391.00 per share. The share of Senores Pharmaceuticals Limited were listed at 609.00 per share and are currently trading at 532.05 per share.

Type :
Sub Sector : Develops And Manufactures A Range Of Pharmaceutical Products Primarily For The Regulated Markets
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
366.70 Cr.

PAT :
47.88 Cr.

Pricing Report

Issue Price :
391.00

Listing Price :
609.00

Current Market Price :
532.05

Issue Price vs CMP :
141.05 (36.07%)

listing Price vs CMP :
76.95 (12.64%)

Performance Report (CAGR* wise)

CAGR : 1987.75
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Senores Pharmaceuticals

Company Information
Senores Pharmaceuticals is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Senores Pharmaceuticals strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing them as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, they strategically identify commercially underpenetrated molecules to launch products in the Regulated and
Show More
Object of Issue
  • Funding the capital expenditure requirements by investment in of one of their Subsidiaries, Havix Group, Inc. d/b/aAavis Pharmaceuticals(“Havix”), for setting up a manufacturing facility for the production of sterile injections in our Atlanta Facility;
  • Re-payment/pre-payment, in full or in part, of certain borrowings availed by the Company and Subsidiaries, namely, Havix, Ratnatris Pharmaceutical Private Limited (“Ratnatris”) and Senores Pharmaceuticals Inc. (“SPI”)
  • Funding the working capital requirements of the Company and their Subsidiaries, namely, SPI and Ratnatris
  • Funding inorganic growth through acquisition and other strategic initiatives and general corporate purposes

Senores Pharmaceuticals MainBoard IPO Details (at the time of IPO)

IPO Type :
Book building
IPO Date :
Dec, 2024
IPO Size :
582.11 Cr.
Market Cap :
1350.70 Cr.   
IPO Subscription :
97.86 X     
PE Multiple :
28.21
Merchant Banker :
Ambit Private Limited
IPO Registrar:
Link Intime India Private Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in Ahmedabad

Adani Power Limited

  power transmission

  Ahmedabad


Adani Wilmar Limited

  FMCG

  Ahmedabad


Asian Granito India Limited

  vitrified tiles

  Ahmedabad


Peer Companies Of This Sector

FAQs

Senores Pharmaceuticals operates in Pharmaceutical and Develops And Manufactures A Range Of Pharmaceutical Products Primarily For The Regulated Markets. The Issue is listed on MainBoard in Dec, 2024. Senores Pharmaceuticals IPO size was 582.11 Cr. with Issue price of 391.00 .

Merchant Banker(s) of Senores Pharmaceuticals IPO: Ambit Private Limited , Equirus Capital Private Limited , Nuvama Wealth Management Limited

Senores Pharmaceuticals IPO subscription was 97.86 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Senores Pharmaceuticals IPO listed at a listing price of 609.00 against the offer price of 391.00.

The current market price of Senores Pharmaceuticals is 532.05.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency